US Broker Ratings

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 20.99% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing the attention of investors with its substantial potential upside of 20.99%, according to analyst ratings. This Utah-based company,..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 64% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within the biotechnology industry. Headquartered in Dublin, Ireland,..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 32.34% Upside Potential

Integer Holdings Corporation (NYSE: ITGR) presents an intriguing opportunity for investors keen on the healthcare sector, specifically within the medical device industry. With a substantial market..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unpacking a 26% Upside Potential

For investors with a keen eye on the healthcare sector, Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity. Known for its robust portfolio of..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a -27% Potential Downside amid Revenue Growth

Oscar Health, Inc. (OSCR), a prominent player in the healthcare technology sector, presents a complex investment profile that demands careful scrutiny from individual investors. Headquartered in..

Halozyme Therapeutics, Inc. (HALO): Investor Outlook and Growth Potential with a Strong Revenue Surge

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has carved a niche in the biotechnology sector with its innovative enzyme-based therapies, positioning itself as a formidable player in the..

Waystar Holding Corp. (WAY) Stock Analysis: 45.66% Upside Potential in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY), a prominent player in the healthcare technology sector, is capturing significant attention from investors with its robust potential upside of 45.66%...

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech with a 56.89% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising clinical-stage cancer therapies. Despite operating at..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 29.48% Potential Upside for Biotech Investors

Bio-Techne Corp (TECH), a significant player in the biotechnology industry, presents a compelling investment opportunity for those eyeing the healthcare sector. With a market capitalization of..

Avantor, Inc. (AVTR) Stock Analysis: A Closer Look at Its 22.76% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.84 billion,..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Biotechnology Innovator with a 47.89% Potential Upside

Roivant Sciences Ltd. (ROIV), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug discovery and development...

Danaher Corporation (DHR) Stock Analysis: A Healthcare Powerhouse with a 23% Upside

Investors looking to navigate the intricate world of healthcare stocks might find Danaher Corporation (NYSE: DHR) particularly enticing. With its robust presence in the diagnostics and..

Veeva Systems Inc. (VEEV) Stock Analysis: Uncovering Growth Potential with a 16.7% Revenue Surge

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences industry, presents a compelling case for investors with its robust revenue..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare with an 18.33% Upside

Teleflex Incorporated (NYSE: TFX) represents a dynamic player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in Wayne, Pennsylvania, the company..

Centene Corporation (CNC) Stock Analysis: Exploring a 35% Potential Upside in the Healthcare Sector

Centene Corporation (NYSE: CNC) is a prominent player in the healthcare sector, catering to under-insured and uninsured families across the United States. Operating through diverse segments..

Teva Pharmaceutical Industries (TEVA): Analyst Consensus Projects 43% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a prominent player in the healthcare sector, has captured investor attention with its strong position in the specialty and generic drug..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 51.63% Potential Upside Amid Robust Revenue Growth

In the dynamic world of biotechnology, TG Therapeutics, Inc. (NASDAQ: TGTX) stands out with its promising outlook and innovative approach to treating B-cell mediated diseases. With..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring a 25.92% Upside with Strategic Innovation in Biotech

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, with a robust market capitalization of $59.67 billion. The company’s strategic focus..

AptarGroup, Inc. (ATR) Stock Analysis: 21.85% Potential Upside Beckons Investors

Investors eyeing AptarGroup, Inc. (NYSE: ATR) may find its current positioning intriguing, especially given the potential upside of 21.85% forecasted by analysts. With a market capitalization..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 9.54% Upside Potential in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is capturing investor attention with its solid market performance and a potential upside of 9.54%...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds